Related Experiment Videos
Scintigraphic aspect of Rotor's disease with technetium-99m-mebrofenin
G LeBouthillier1, J Morais, M Picard
1Division of Nuclear Medicine, Hôpital Saint-Luc, Université de Montréal, Quebec, Canada.
Abstract:
A 28-yr-old male with Rotor's disease was studied with 99mTc-mebrofenin. The scintigraphic pattern was that of a slow liver uptake with unimpaired excretion and persistent visualization of the cardiac blood pool, kidneys and urinary tract up to 6 hr. The gallbladder was visualized at 55 min postinjection.
Insights
Rotor
Area of Science:
- Hepatobiliary imaging
- Nuclear medicine
- Diagnostic radiology
Background:
- Rotor's disease is a rare inherited disorder affecting bilirubin metabolism.
- Accurate diagnosis and monitoring are crucial for patient management.
Observation:
- A 28-year-old male patient with Rotor's disease underwent scintigraphy using 99mTc-mebrofenin.
- The study involved dynamic imaging to assess liver function and biliary excretion.
Findings:
- Scintigraphy revealed slow hepatic uptake of 99mTc-mebrofenin.
- Unimpaired biliary excretion was observed, with persistent visualization of the cardiac blood pool, kidneys, and urinary tract for up to 6 hours.
- Gallbladder visualization occurred at 55 minutes post-injection.
Implications:
- This case highlights the characteristic scintigraphic findings in Rotor's disease.
- 99mTc-mebrofenin scintigraphy can aid in differentiating Rotor's disease from other cholestatic conditions.
- Understanding the dynamic imaging patterns is essential for accurate diagnosis.